(BV) BrightView Holdings - Overview
Stock: Landscaping, Maintenance, Development, Irrigation, Snow
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 38.6% |
| Relative Tail Risk | -10.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.27 |
| Alpha | -30.05 |
| Character TTM | |
|---|---|
| Beta | 0.876 |
| Beta Downside | 0.609 |
| Drawdowns 3y | |
|---|---|
| Max DD | 37.32% |
| CAGR/Max DD | 0.75 |
Description: BV BrightView Holdings January 15, 2026
BrightView Holdings (NYSE:BV) is the largest U.S. commercial landscaping provider, operating through two segments: Maintenance Services, which supplies recurring care such as mowing, irrigation, snow removal, and tree work to a broad client base (corporate campuses, HOAs, municipalities, hospitals, schools, hotels, resorts, and golf courses); and Development Services, which handles design-build projects-including landscape architecture, irrigation and specialty turf installations-and serves as the official field consultant to Major League Baseball. The firm traces its roots to 1939 and is headquartered in Blue Bell, Pennsylvania.
According to the company’s most recent 10-K (FY 2023), BrightView generated roughly **$1.2 billion in revenue** with an **adjusted EBITDA margin of ~9%** and reported a **backlog of about $400 million**, indicating a pipeline of multi-year contracts. Key economic drivers include commercial real-estate occupancy trends (higher office and retail tenancy boosts recurring maintenance spend) and municipal infrastructure budgets, while sector-wide forces such as **increasing regulatory pressure for water-efficient landscaping** and the **shift toward sustainable, low-carbon grounds-keeping** are expanding demand for premium irrigation and turf-management services.
For a deeper, data-rich view of BrightView’s valuation dynamics, you may find ValueRay’s analyst platform useful as a next step in your research.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 56.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -2.57 > 1.0 |
| NWC/Revenue: 5.68% < 20% (prev 8.56%; Δ -2.88% < -1%) |
| CFO/TA 0.09 > 3% & CFO 291.8m > Net Income 56.0m |
| Net Debt (3.70m) to EBITDA (310.1m): 0.01 < 3 |
| Current Ratio: 1.30 > 1.5 & < 3 |
| Outstanding Shares: last quarter (97.7m) vs 12m ago 1.11% < -2% |
| Gross Margin: 23.26% > 18% (prev 0.23%; Δ 2303 % > 0.5%) |
| Asset Turnover: 78.80% > 50% (prev 81.58%; Δ -2.78% > 0%) |
| Interest Coverage Ratio: 2.52 > 6 (EBITDA TTM 310.1m / Interest Expense TTM 55.0m) |
Altman Z'' 0.55
| A: 0.04 (Total Current Assets 666.3m - Total Current Liabilities 514.5m) / Total Assets 3.39b |
| B: -0.00 (Retained Earnings -12.9m / Total Assets 3.39b) |
| C: 0.04 (EBIT TTM 138.6m / Avg Total Assets 3.39b) |
| D: -0.01 (Book Value of Equity -12.7m / Total Liabilities 1.59b) |
| Altman-Z'' Score: 0.55 = B |
Beneish M -3.36
| DSRI: 0.74 (Receivables 393.1m/553.0m, Revenue 2.67b/2.77b) |
| GMI: 0.99 (GM 23.26% / 23.01%) |
| AQI: 0.99 (AQ_t 0.62 / AQ_t-1 0.63) |
| SGI: 0.97 (Revenue 2.67b / 2.77b) |
| TATA: -0.07 (NI 56.0m - CFO 291.8m) / TA 3.39b) |
| Beneish M-Score: -3.36 (Cap -4..+1) = AA |
What is the price of BV shares?
Over the past week, the price has changed by +1.42%, over one month by +4.15%, over three months by +13.96% and over the past year by -9.91%.
Is BV a buy, sell or hold?
- StrongBuy: 6
- Buy: 1
- Hold: 1
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the BV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 16.2 | 19.3% |
| Analysts Target Price | 16.2 | 19.3% |
| ValueRay Target Price | 13.3 | -2% |
BV Fundamental Data Overview February 04, 2026
P/E Forward = 10.1112
P/S = 0.4889
P/B = 0.9698
P/EG = 4.04
Revenue TTM = 2.67b USD
EBIT TTM = 138.6m USD
EBITDA TTM = 310.1m USD
Long Term Debt = 790.2m USD (from longTermDebt, last quarter)
Short Term Debt = 94.2m USD (from shortTermDebt, last quarter)
Debt = 78.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.70m USD (from netDebt column, last quarter)
Enterprise Value = 1.31b USD (1.31b + Debt 78.2m - CCE 74.5m)
Interest Coverage Ratio = 2.52 (Ebit TTM 138.6m / Interest Expense TTM 55.0m)
EV/FCF = 34.86x (Enterprise Value 1.31b / FCF TTM 37.6m)
FCF Yield = 2.87% (FCF TTM 37.6m / Enterprise Value 1.31b)
FCF Margin = 1.41% (FCF TTM 37.6m / Revenue TTM 2.67b)
Net Margin = 2.10% (Net Income TTM 56.0m / Revenue TTM 2.67b)
Gross Margin = 23.26% ((Revenue TTM 2.67b - Cost of Revenue TTM 2.05b) / Revenue TTM)
Gross Margin QoQ = 25.11% (prev 24.13%)
Tobins Q-Ratio = 0.39 (Enterprise Value 1.31b / Total Assets 3.39b)
Interest Expense / Debt = 17.14% (Interest Expense 13.4m / Debt 78.2m)
Taxrate = 34.52% (14.6m / 42.3m)
NOPAT = 90.8m (EBIT 138.6m * (1 - 34.52%))
Current Ratio = 1.30 (Total Current Assets 666.3m / Total Current Liabilities 514.5m)
Debt / Equity = 0.06 (Debt 78.2m / totalStockholderEquity, last quarter 1.29b)
Debt / EBITDA = 0.01 (Net Debt 3.70m / EBITDA 310.1m)
Debt / FCF = 0.10 (Net Debt 3.70m / FCF TTM 37.6m)
Total Stockholder Equity = 1.66b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.65% (Net Income 56.0m / Total Assets 3.39b)
RoE = 3.38% (Net Income TTM 56.0m / Total Stockholder Equity 1.66b)
RoCE = 5.67% (EBIT 138.6m / Capital Employed (Equity 1.66b + L.T.Debt 790.2m))
RoIC = 4.39% (NOPAT 90.8m / Invested Capital 2.07b)
WACC = 9.26% (E(1.31b)/V(1.39b) * Re(9.14%) + D(78.2m)/V(1.39b) * Rd(17.14%) * (1-Tc(0.35)))
Discount Rate = 9.14% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.98%
[DCF Debug] Terminal Value 64.74% ; FCFF base≈72.5m ; Y1≈47.6m ; Y5≈21.7m
Fair Price DCF = 3.65 (EV 348.6m - Net Debt 3.70m = Equity 344.9m / Shares 94.5m; r=9.26% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -2.39 | EPS CAGR: 38.32% | SUE: -0.96 | # QB: 0
Revenue Correlation: 2.86 | Revenue CAGR: 4.69% | SUE: -1.39 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.11 | Chg30d=+0.001 | Revisions Net=-6 | Analysts=8
EPS current Year (2026-09-30): EPS=0.78 | Chg30d=+0.002 | Revisions Net=-7 | Growth EPS=+3.0% | Growth Revenue=+0.8%
EPS next Year (2027-09-30): EPS=0.88 | Chg30d=+0.038 | Revisions Net=-3 | Growth EPS=+12.2% | Growth Revenue=+2.7%